AAA March 2017 – Page 2

Twist reveals $33m in funding

Twist Bioscience, a US-based DNA manufacturing technology developer backed by genomics technology company llumina, pharmaceutical firm WuXi PharmaTech and biotechnology producer Institut Mérieux, received $33m from undisclosed investors on Monday. Twist is developing a semiconductor-based process that uses silicon to produce synthetic DNA for eventual use in areas such as personalised medicines and pharmaceuticals, sustainable… Continue reading Twist reveals $33m in funding

Phoenix rises with corporate-backed fund

US-based venture capital firm Phoenix Venture Partners closed its second fund on Monday with limited partners that included pharmaceutical firm Pfizer, manufacturing conglomerate 3M and glass and ceramics materials producer Corning. Chemical producers Eastman Chemical, Solvay and Showa Denko, and manufacturing company WL Gore & Associates have also contributed to PVP II fund, the size… Continue reading Phoenix rises with corporate-backed fund